Why Need to Watch: Chesapeake Energy Corporation (NYSE:CHK), Goldcorp Inc. (NYSE:GG), CYS Investments, Inc. (NYSE:CYS), Smith & Wesson (NASDAQ:SWHC), ACADIA Pharmaceuticals (NASDAQ:ACAD)

Chesapeake Energy Corporation (NYSE:CHK) belongs to Basic Materials sector. Its net profit margin is -15.40% and weekly performance is 1.30%. On last trading day company shares ended up $14.76. Chesapeake Energy Corporation (NYSE:CHK) distance from 50-day simple moving average (SMA50) is -0.33%. Chesapeake Energy Corporation (NYSE:CHK) said that, its 4.50% Cumulative Convertible Preferred Stock will trade ex-dividend, for its quarterly dividend of $1.125, payable on 6/15/15.

Goldcorp Inc. (NYSE:GG) shares moved up 0.46% in last trading session and ended the day at $17.57. GG Gross Margin is 15.30% and its return on assets is -8.00%. Goldcorp Inc. (NYSE:GG) quarterly performance is -17.97%. On 19 May, Goldcorp Inc. (NYSE:GG) said that, it has once again been named to the semi-annual re-ranking of the NASDAQ OMX CRD Global Sustainability Index for the second consecutive time.

On 27 May, CYS Investments, Inc. (NYSE:CYS) shares moved up 0.34% and was closed at $8.94. CYS EPS growth in last 5 year was -12.00%. CYS Investments, Inc. (NYSE:CYS) year to date (YTD) performance is 5.97%. CYS Investments, Inc. (NYSE:CYS) announced that Kevin E. Grant, CFA, the Company’s CEO and President, will deliver a presentation at the KBW Mortgage Finance Conference at the Millennium Broadway Hotel in New York City on Tuesday, June 2, 2015 at approximately 9:45 a.m. (ET).

Smith & Wesson Holding Corporation (NASDAQ:SWHC) ended the last trading day at $14.93. Company weekly volatility is calculated as 2.31% and price to cash ratio as 13.60. Smith & Wesson Holding Corporation (NASDAQ:SWHC) showed a weekly performance of -2.86%.RBC Capital began coverage on shares of Smith & Wesson Holding Corporation (NASDAQ:SWHC) in a report released on Monday. The firm issued a sector perform rating and a $16.00 price objective on the stock.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares advanced 1.80% in last trading session and ended the day at $40.82. ACAD return on assets is -40.00%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) quarterly performance is 9.14%.ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that it will present at the Jefferies 2015 Healthcare Conference on Tuesday, June 2, 2015, at 1:30 p.m. Eastern Time in New York City.

Leave a Reply

Your email address will not be published. Required fields are marked *